Oric Pharmaceuticals, Inc. Common Stock (ORIC) Stock
NASDAQ · ORIC
12.79
Fundamentals
Market cap
$1.33B
Price / Earnings ratio
-9.5x
Price / Sales ratio
N/A
Price / Book ratio
3.5x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Oric Pharmaceuticals, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees111
CEODr. Jacob M. Chacko M.B.A., M.D.
IPO DateApr 24, 2020
HeadquartersSouth San Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Richard A. Heyman Ph.D. | Founder, Independent Chairman & Member of Scientific Advisory Board | 1957 |
| Dr. Jacob M. Chacko M.B.A., M.D. | President, CEO & Director | 1979 |
| Mr. Dominic G. Piscitelli CPA, M.B.A. | Chief Financial Officer | 1975 |
| Dr. Pratik S. Multani M.D., M.S. | Chief Medical Officer | 1967 |
| Dr. Charles L. Sawyers B.A., M.D., Ph.D. | Founder & Member of Scientific Advisory Board | 1959 |
| Dr. Scott W. Lowe Ph.D. | Founder & Member of Scientific Advisory Board | — |
| Dr. Kevin Brodbeck Ph.D. | Chief Technical Officer | — |
| Dr. Lori Sickels Friedman Ph.D. | Chief Scientific Officer | 1965 |
| Dr. Christian V. Kuhlen Esq., J.D., M.D. | General Counsel | 1973 |
| Mr. Daniel Iazzetti | VP & Head of People | — |
Fundamentals
Valuation
Market cap$1.33B
Price-to-sales ratioN/A
Price-to-book value3.50
Price-earnings ratio-9.50
Return on Equity-35.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.32
Income Statement
Average volume1,187,677
EBITDA$-134.03M
1 year high (52w)$14.93
1 year low (52w)$7.23
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



